Takeda Pharmaceutical Company Limited

Equity-NMS: TAK

Healthcare | Drug Manufacturers - Specialty & Generic

$18.74-0.03 (April 3, 2026)

Takeda Pharmaceutical Company Limited Chart

Takeda Pharmaceutical Company Limited Performance

Days Range

Previous Close: $18.77
Open: $18.56
EPS(TTM): 0.22
Shares O/S: 3.16 B
Day's Range$18.46 - $18.83
52W Range$12.99 - $18.895
Market Cap59.2 B

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.

Frequently Asked Questions

Takeda Pharmaceutical Company Limited (TAK) share price as of April 3, 2026 is $18.74. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Takeda Pharmaceutical Company Limited (TAK) Share by opening an international trading account with Angel One.
Purchasing Takeda Pharmaceutical Company Limited (TAK) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Takeda Pharmaceutical Company Limited (TAK) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Takeda Pharmaceutical Company Limited (TAK) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Takeda Pharmaceutical Company Limited on February 11, 2026, is $59.2 B.
Takeda Pharmaceutical Company Limited operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
In order to invest in Takeda Pharmaceutical Company Limited (TAK) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Open Free Demat Account!
Join our 3.5 Cr+ happy customers